Skip to Main Content

Try STAT+ TODAY

cholesterol

Most Read

Pharmalot Ed Silverman

Amgen may face tougher insurance coverage for its cholesterol drug

Pharmalot Ed Silverman

Amgen cholesterol drug cuts heart risks in a closely watched study

Pharmalot Ed Silverman

Is it in the public’s interest to have two similar cholesterol drugs on the market?

Health Associated Press

Cholesterol drug shows promise to help reverse heart disease

Pharmalot Ed Silverman

Pfizer stops developing a cholesterol drug. So who is the big winner?

Health Damian Garde

Raising ‘good’ cholesterol doesn’t protect against heart disease after all, study finds

Biotech Damian Garde

These pricey cholesterol drugs aren’t selling. And that has the biotech industry sweating

Health Associated Press

Testing cholesterol in toddlers and babies? Study says it could help

All Coverage

The Watchdogs Ivan Oransky and Adam Marcus

Why a drug that lowers cholesterol doesn’t save lives

Pharmalot Ed Silverman

Aegerion to pay $40M and plead guilty to illegally marketing cholesterol drug

advertisement

Pharmalot Ed Silverman

Pharmalot, Pharmalittle: Cigna to get discounts if cholesterol meds don’t work

Pharmalot Ed Silverman

What generics? Americans spent an extra $73b for brand-name meds

First Opinion Patrick Skerrett

New guidelines simplify cholesterol tests: no fasting needed

Pharmalot Ed Silverman

Pharmalot, Pharmalittle: Little company makes big bet on discarded Roche drug

Pharmalot Ed Silverman

Docs won’t prescribe pricey new cholesterol meds unless they lower heart risks

Pharmalot Ed Silverman

Pharmalot, Pharmalittle: Docs puzzle over cholesterol drug results

Health Associated Press

Cholesterol-lowering statins cut heart disease risk in people with slightly high blood pressure

Pharmalot Ed Silverman

Why one analyst thinks a Sanofi and Regeneron cholesterol drug will be yanked

In the Lab Elie Dolgin

Jewish grandma’s DNA points to new ways of treating heart disease

In the Lab Eric Boodman

‘Essential’ genes may not be so essential after all

Pharmalot Ed Silverman

Pharmalot, Pharmalittle: setback for Merck, Valeant to offer discounts at Walgreens

Pharmalot Ed Silverman

Pharmalot, Pharmalittle: US drug prices are highest, UnitedHealth favors Regeneron

Pharmalot Ed Silverman

Pharmalot, Pharmalittle: CVS covers new cholesterol drug, FDA Duchenne hearing

Pharmalot Ed Silverman

Pharmalot, Pharmalittle: cholesterol fighter rejected, antibiotics survey

Pharmalot Ed Silverman

Pharmalot, Pharmalittle: Merck, PBMs, and lung cancer drug